BACKGROUND: Tumor necrosis factor a (TNFa), a cytokine produced at in¯ammatory sites and in adipose tissue, is known primarily for its detrimental effects on insulin action. There is evidence to suggest that TNFa may also in¯uence b-cell function. Leptin is another adipose tissue-derived hormone that might also act on b-cells. OBJECTIVE: We explored the independent and combined effects of TNFa and leptin upon basal and glucose-stimulated insulin transcription and secretion in the HIT-T15 pancreatic b cell line. METHODS: Cells were cultured for 40 h in the presence of near-normal basal (7 mM) or high (16.7 mM) glucose and treated with either TNFa (1, 10 and 50 ngaml) or leptin (10, 50 and 100 ngaml) or both together. Insulin concentrations were measured by radioimmunoassay. Insulin mRNA levels were evaluated by a semi-quantitative reverse transcription-polymerase chain reaction (RT-PCR) method, after normalization with b-actin mRNA. RESULTS: TNFa signi®cantly suppressed basal and glucose-stimulated insulin secretion and proinsulin mRNA transcription in a dose-dependent manner, an effect that was more powerful in the presence of high glucose. Leptin also inhibited dosedependent insulin mRNA and protein at both glucose concentrations, but did not appear to further potentiate the suppressive effects of TNFa. CONCLUSION: TNFa suppresses both basal and glucose-stimulated insulin transcription and secretion in HIT-T15 cells, an effect that is enhanced signi®cantly by high glucose. Leptin also independently inhibits basal and glucose-stimulated insulin secretion and transcription but does not modify TNFa effects. These effects might contribute to the abnormalities of glucose metabolism that characterize conditions of increased TNFa andaor leptin production.
Introduction
Tumor necrosis factor (TNF)-a is a pluripotent cytokine produced mainly at sites of in¯ammation, which together with IL-6 and IL-1 mediates the local and systemic in¯am-matory response. TNFa is also overexpressed in the adipose tissue of both animal models of obesity and obese humans, and there is evidence to suggest that adipose tissue-derived TNFa is a key mediator of obesity-induced insulin resistance. 1 ± 5 TNFa acting through its receptors (p55 andaor p75) interferes directly with insulin signaling not only in adipose cells, 6, 7 but also in other insulin sensitive tissues, such as the muscle and the liver. 8 ± 10 Recent studies in the b pancreatic cell line, INS-1, have suggested that TNFa might also directly act on b-cells and exert some inhibitory effects on glucose-stimulated insulin secretion. 11 Leptin is another adipose tissue-derived hormone, also overproduced in obesity, that, in addition to its well-known neuroendocrine effects on the hypothalamus to regulate food intake and energy metabolism, 12, 13 might also act on pancreatic b-cells to in¯uence insulin secretion. 14 The effects of leptin on insulin secretion have been studied extensively in insulinoma cells and pancreatic islets, with con¯icting results. Thus, leptin at concentration of 1 ± 100 nM, could inhibit acutely and chronically basal and glucose-stimulated insulin release in both human and rodent islets and cultured insulinoma cells. 15 ± 18 Moreover, leptin suppressed glucose or GLP-1 induced proinsulin gene transcription in isolated islets and b pancreatic cells. 17, 19, 20 In obaob mice, the animal model of obesity showing metabolic abnormalities similar to those seen in obese type 2 diabetic humans, daily administration of leptin could lower serum insulin and glucose levels, independently of its weight reducing effect. 21, 22 Other studies, however, have either failed to show any effect on insulin release from isolated rat pancreases, 23 or have shown a stimulatory effect of leptin on basal but not glucose-stimulated insulin secretion and biosynthesis in pancreatic b cells. 24, 25 This study examines the direct independent and combined effects of TNFa and leptin on insulin secretion and preproinsulin gene transcription in a b pancreatic cell line, the HIT-T15, at near-normal (7 mM) and high (16.7 mM) glucose concentrations. We demonstrate that leptin Ð at concentrations usually circulating in obese individuals Ð and TNFa can have a direct action on b pancreatic cells, and supress both basal and glucose-stimulated insulin secretion and preproinsulin gene transcription over a period of 40 h. These direct effects might provide another mechanism via which overproduction of TNFa andaor leptin contribute to the abnormalities of glucose homeostasis observed in obese individuals.
Methods
Cell culture and measurement of insulin secretion HIT-T15 cells (passage 61) was obtained from the American Type Culture Collection (ATCC). HIT-T15 is a Syrian hamster insulinoma b cell line, established from a primary culture of pancreatic islet cells which were transformed with the SV40 virus. 26 The insulin secreting ability of these cells is stimulated by glucose and glucagon and suppressed by somatostatin and glucocorticoids which makes them a good in vitro model for studying glucose-stimulated insulin secretion. HIT-T15 cells respond to glucose by increasing insulin release, as well as insulin biosynthesis rate and preproinsulin mRNA levels.
HIT-T15 cells (passages 66 ± 74) were cultured in F-12K medium supplemented with 10% horse serum, 2.5% fetal calf serum and penicillinastreptomycin in an atmosphere of 5% CO 2 at 37 C. Cells were subcultured with EDTA and trypsin (0.25%) in Ca 2 -, Mg 2 -free PBS solution. For the experiments, cells were plated at a density of 1Â10 6 cellsawell in a 12-well plates in 1.5 ml of medium. Cell viability and cell counting were done using the trypan blue exclusion. Cells were left for 24 h to attach, before changing the medium. HIT-T15 cells were incubated further with either F-12K medium containing 7 mM glucose or with F-12K medium supplemented with 16.7 mM glucose and were exposed to different concentrations of either recombinant murine TNFa (1, 10 and 50 ngaml; R&D Systems, Oxon, UK), or mouse leptin (10, 50 and 100 ngaml; R&D Systems, Oxon, UK), or combination of TNFa and leptin. Control cells were incubated in either 7 mM glucose F-12K or 16.7 mM glucose F-12K medium. All cells were left to incubate for 40 h and, after this period, the medium was collected, centrifuged (10 000 rpm, 5 min), and stored at 7 20 C for insulin measurement by RIA (DiaSorin, Sorin Diagnostics, Saluggia, Italy). At the same time total RNA was extracted from cells.
RNA preparation
Total RNA was isolated from the HIT-T15 pancreatic cells using the TriPure Isolation Reagent (Roche Molecular Biochemicals, Mannheim, Germany); 1 mla1Â10 6 cells). The integrity of RNA samples was determined on agarose gels (1.2%) and spectrophotometrically using the absorption ratio at 260a280 nm. The RNA quanti®cation was done by measuring the absorption at 260 nm.
For the removal of any residual DNA contamination, RNA samples were preincubated with DNase I (Promega, Madison, USA), at 37 C for 25 min, and then inactivated at 65 C for 5 min before the reverse transcription and PCR method.
Semi-quantitative RT-PCR analysis
The RT-PCR (reverse transcription-polymerase chain reaction) method was performed using the Titan One tube RT-PCR system (Roche Molecular Biochemicals, Mannheim, Germany) according to the manufacturer's instructions. The RT-PCR was done in one step and in the same tube using a Perkin-Elmer 9600 thermocycler. Brie¯y, after the reverse transcription reaction which took place at 49 C for 40 min, there followed 10 PCR cycles at 94 C for 30 s, 60 C for 30 s, and 68 C for 55 s. These were followed by 11 additional PCR cycles with the same denaturing and annealing steps, increasing the elongation step in each one of them by 5 s. Finally, the reaction was completed with 14 PCR cycles at 94 C for 30 s, at 60 C for 30 s and at 68 C for 115 s.
Each semi-quantitative RT-PCR reaction was performed with 0.5 mg of total RNA in a ®nal volume of 25 ml, using 20 pmol of each preproinsulin primer and 5 pmol for each b-actin primers.
A set of speci®c primers (5
H , and 5'-GGTAGAGGGAGCAGATGCTGGTGC-3 H ) was used in order to amplify a 229 bp PCR product from the preproinsulin mRNA transcript (GenBank account, no. X04724). A second set of primers (5 H -CCAAGGCCAACCGC-GAGAAGATGAC-3
H and 5 H -AGGGTACATGGTGGTGCCAC-CAGAC-3 H ) was also used that recognized and ampli®ed a PCR product of 582 bp in the mouse b-actin mRNA (GenBank account no. X03672). All primers were chosen to lie in different exons and to¯ank intron sequences.
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Image analysis documentation system All PCR products were run on 1.2 ± 1.5% agarose gels and were visualized with ethidium bromide staining. Product lengths were estimated using standard molecular weight markers (pUC18-HinfI). Data were collected and analyzed by an ImageMaster VDS Analyser System (Pharmacia, Upsala, Sweden). The mean integrated optical density of each PCR band was determined by the program according to a density calibration step tablet after subtraction of the background. Measurements for each PCR band were normalized, using the corresponding integrated optical density of the b-actin mRNA as an internal standard. Expression of preproinsulin transcript was referred as relative integrated optical density units.
Statistical analysis
Statistical analysis was performed using the SPSS for Windows 1997-version 8.0 software (Chicago, Illinois). Data are expressed as means AE s.e.m. Comparisons between the mean values of independent parameters were done with the non-parametric Mann ± Whitney test. The upper level of statistical signi®cance was chosen to be equal to 5%.
Results
Effect of TNFa on basal (7 mM) and glucose-stimulated (16.7 mM) insulin secretion of HIT-T15 cells TNFa at concentrations of 1, 10 and 50 ngaml signi®cantly and dose-dependently suppressed insulin secretion (by 5.5, 13 and 25%, respectively, P`0.02) in HIT-T15 pancreatic cells cultured in 7 mM glucose ( Figure 1A ). At 16.7 mM glucose, the suppression of glucose stimulated insulin secretion was more profound by all three TNFa concentrations (by 30, 32 and 36%, respectively, P`0.001, Figure 1A ).
Effect of TNFa on preproinsulin mRNA expression of HIT-T15 cells TNFa at concentrations of 1, 10 and 50 ngaml inhibited signi®cantly and dose-dependently preproinsulin transcription at both 7 mM (by 15, 15 and 43%, respectively; P`0.03) and 16.7 mM glucose (by 30%, 34% and 52%, respectively; P`0.002; Figure 1B ). The suppressive effect of TNFa on preproinsulin mRNA expression was more potent at the higher glucose concentration ( Figure 1B) .
Effect of leptin on basal (7 mM) and glucose-stimulated (16.7 mM) insulin secretion of HIT-T15 cells Leptin at the two lower concentrations employed, 10 and 50 ngaml, did not exert any signi®cant effect on insulin secretion in cells cultured with 7 mM glucose ( Figure 2A) . However, the highest leptin concentration used, 100 ngaml, showed signi®cant suppression of insulin secretion (by 9%, P`0.01) at the above glucose level (Figure 2A) . Furthermore, all three leptin concentrations (10, 50 and 100 ngaml) showed a dose-dependent suppression of glucose-stimulated insulin secretion (by 6.5, 18 and 30%, respectively, Figure 2A ), which reached signi®cance (P`0.002) for the two highest leptin concentrations (Figure 2A ). 
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Effect of leptin on preproinsulin mRNA transcription of HIT-T15 cells At 7 mM glucose the two lower leptin doses of 10 and 50 ngaml showed no signi®cant effect on preproinsulin transcription during the 40 h incubation, whereas the highest leptin concentration of 100 ngaml signi®cantly reduced (by 29%, P`0.001) preproinsulin mRNA expression ( Figure 2B ). However, at 16.7 mM glucose all three leptin concentrations suppressed in a dosedependent manner glucose-stimulated proinsulin mRNA expression (by 15, 22 and 34%, respectively, Figure 2B ), an effect that again reached signi®cance with the two Combined TNFa and leptin effects on basal glucose (7 mM) insulin secretion of HIT-T15 cells The addition of 10 or 100 ngaml of leptin to the lowest TNFa dose (1 ngaml) resulted in a further signi®cant suppression (by approximately 23.5%, P`0.01) of insulin secretion at 7 mM glucose concentration ( Figure 3A) . However, the addition of 10 or 100 ngaml of leptin to 10 or 50 ngaml of TNFa did not appear to further suppress signi®cantly basal insulin secretion ( Figure 3A) .
Combined TNFa and leptin effects on glucose-stimulated (16.7 mM) insulin secretion of HIT-T15 cells At 16.7 mM glucose, the combined exposure to any of the three concentrations of TNFa (1, 10 and 50 ngaml) together with 10 or 100 ngaml of leptin did not further suppress signi®cantly glucose-stimulated insulin secretion ( Figure 3B ). There was a tendency to do so, however, with the higher leptin concentration of 100 ngaml.
Combined TNFa and leptin effects on basal (7 mM) and glucose-stimulated (16.7 mM) preproinsulin mRNA expression of HIT-T15 cells Basal and glucose stimulated preproinsulin transcription was signi®cantly suppressed at all three TNFa concentrations ( Figure 4 ). Neither at 7 mM nor at 16.7 mM glucose, however, did the addition of 10 or 100 ngaml of leptin appear to further suppress signi®cantly preproinsulin expression ( Figure 4A and B) .
In all the above experiments, no change on b-actin mRNA levels was observed after incubation of the HIT-T15 b cells with either glucose, TNFa or leptin, suggesting that the effect of these agents was speci®c on the insulin secretion and preproinsulin mRNA levels.
Discussion
This study investigates the direct actions of TNFa and leptin on the b pancreatic cell. We examined the independent and combined effects of TNFa and leptin on basal and glucoseinduced insulin secretion and transcription in the b pancreatic cell line HIT-T15. We demonstrate that exposure of HIT-T15 cells for 40 h to leptin concentrations within the range seen in obesity (10, 50 and 100 ngaml) or to 1, 10 and 50 ngaml of TNFa signi®cantly suppresses insulin secretion and preproinsulin mRNA in a dose-dependent fashion, both at near normal and high prevailing glucose concentrations. When HIT-T15 cells were exposed to TNFa and leptin together, an additional suppressive effect on insulin secretion was observed only with the smaller TNFa concentration of 1 ngaml at basal glucose concentration. With regard to preproinsulin expression, the addition of leptin did not further potentiate the effects of TNFa in our system. These ®ndings are apparently subject to the limitations of using a 
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PC Tsiotra et al Figure 4 The combined effects of TNFa and leptin on basal (7 mM glucose) (A) and glucose-stimulated (16. Previous studies have also shown suppression of glucoseinduced insulin secretion by TNFa. 11 We demonstrate that this inhibitory effect does not only manifest at the secretion level, but is also quite powerful at the transcription level, even with the smaller TNFa concentration of 1 ngaml tested. The exact mechanisms for TNFa actions on insulin secretion are unclear. TNFa action involves many different nuclear factors, such as NF-kB, the AP-1 family of transcription factors (c-fos and c-jun) and the CaERB family, which control the transcription of different genes, as well as the MAP kinases, the iNOS gene, and the family of caspases that control apoptotic pathways. 27 ± 29 In addition, TNFa downregulates the expression of Glut4 and phosphorylates serine residues on the insulin receptor substrate IRS-1, thereby diverting insulin signaling from its normal pathway into an inhibited signaling state. 6 ± 8 TNFa activity has been shown to exist in pancreatic islets and in insulinoma cells. 30, 31 Thus, the mechanism of TNFa-mediated insulin resistance that exist in peripheral tissues, could also be expected to operate on pancreatic b-cells and in¯uence their function, as they also express insulin receptors that are required for normal glucose-stimulated insulin secretion. 5 Interestingly, it was demonstrated that insulin receptor signaling also appears to in¯uence insulin gene expression and insulin content in the b-cell. 32, 33 TNFa exerts its actions through either the p55 andaor p75 receptor. 34 It is of note that primary b pancreatic cells and insulinoma cells have been shown to express low levels of the p55 receptor but not the p75 receptor. 31 The potential cytotoxic effects of TNFa on HIT-T15 cells has not been examined in our study. This possibility seems unlikely, however, given that the cytotoxic effects of TNFa on b-cells apparently require higher concentrations of TNFa, 35 or the simultaneous presence of other cytokines such as IFN-g andaor IL-1b, 36 ± 38 which was not the case in our system.
With regard to leptin effects, it is of note that 10 ngaml of leptin, which falls within the physiological range of circulating leptin levels in lean subjects, did not appreciably in¯u-ence insulin secretion or transcription in HIT-T15 cells over a time period of 40 h. With increasing leptin concentrations, however, which still remain within the range of circulating levels in obesity (50 and 100 ngaml), we observed signi®cant inhibition of both insulin secretion and transcription that was more potent with the higher prevailing glucose concentration. Assuming that circulating leptin levels re¯ect the local concentration in the pancreas, our in vitro observations are most likely to be physiologically relevant. Consistent with our ®nding, acute exposure of perfused pancreases or isolated islets from obaob mice and normal rodents to physiological levels of leptin did not appreciably in¯uence basal and glucose-stimulated insulin. 16, 39 Acute exposure, however, of rat and human pancreatic islets 18, 40 or perfused pancreases from obaob mice to higher leptin levels (obese range), resulted in a potent dose-dependent inhibition of glucose-stimulated insulin secretion. 16 In addition, it has been shown that a single injection of leptin inhibits insulin gene transcription and reverses hyperinsulinemia in leptinde®cient obaob mice, 20 an effect that is apparently independent of any changes in body weight. Suppression of insulin secretion and gene transcription by leptin in the obese range has also been demonstrated in human pancreatic islets. 15, 17 It should be noted, however, that not all studies have reported inhibitory effects of leptin on insulin secretion. Thus, Shimizu et al, 24 and Tanizawa et al, 25 have actually shown stimulation of insulin secretion by leptin at a physiological range of concentrations, in HIT-T15 and MIN-6 cells, respectively. One possibility for this difference might be the much shorter incubation times (2 ± 24 h) used by these authors, and possibly the fact that they used only basal glucose concentrations in their experiments. 24 Another mechanism by which leptin might in¯uence bcell function, is by reducing the TG content of pancreatic cells, 48, 49 an effect which may actually protect rat islets from the cytotoxic effects of IL-1b. 50 It must be noted that the putative functional form of the leptin receptor is expressed in rodent and human pancreatic islets and insulinoma cell lines, 16, 20, 41, 45 strongly suggesting that the observed leptin actions are receptor mediated. Leptin receptor mediates leptin actions through activation of the janus activated kinases (JAK) and the STAT members of transcription factors, 42, 43 although its signaling capabilities seem to diverge due to the existence of various leptin receptor isoforms. 44 The intracellular mechanisms via which leptin might exert its effects on b-cell function have been more extensively studied. It has been suggested that leptin suppresses insulin secretion by acting on K ATP channels, 17, 20, 45 andaor by reducing the activity of the Ca 2 -dependent PKC isoform. 40 Recently, it was also proposed that short-term inhibition of insulin secretion by leptin is mediated through activation of the phosphodiesterase 3B (PBE3B) and subsequent suppression of cAMP levels. 46, 47 In addition, there has been evidence that leptin reduces the transcriptional activity of the rat insulin I gene promoter and alters the binding of distinct proteins to upstream sequences within the 5 H promoter region of the insulin gene. 20 Despite the independent signi®cant inhibitory actions of TNFa and leptin on insulin secretion and gene transcription, only at the smallest TNFa concentration (1 ngaml) did addition of leptin cause signi®cant further suppression of basal insulin secretion. At the higher TNFa concentrations, leptin tended to, but did not signi®cantly, potentiate either of TNFa actions. This might be explained by the more powerful suppression of both insulin secretion and gene transcription by the high TNFa concentrations, that did not allow further changes by leptin.
In conclusion, TNFa and leptin have independent direct inhibitory effects on insulin secretion and transcription in vitro, which are more powerful at high prevailing glucose concentrations. Given that both of these cytokinesahormones Inhibition of insulin transcription by TNFa and leptin PC Tsiotra et al are overproduced in the adipose tissue of obese individuals and released into the circulation, they may modify the insulin secretory response directly and could be involved in the pathogenesis of the diabetic syndrome in obesity.
